N0321: A phase II study of bortezomib, paclitaxel, carboplatin (CBCDA), and radiotherapy (RT) for locally advanced non-small cell lung cancer (NSCLC).
Steven E. Schild
No relevant relationships to disclose
Nathan R. Foster
No relevant relationships to disclose
Julian R. Molina
No relevant relationships to disclose
Grace K. Dy
No relevant relationships to disclose
Kendrith M. Rowland
No relevant relationships to disclose
Jann Nagina Sarkaria
No relevant relationships to disclose
Sachdev P. Thomas
No relevant relationships to disclose
Donald W. Northfelt
No relevant relationships to disclose
John William Kugler
No relevant relationships to disclose
Alex A. Adjei
No relevant relationships to disclose